Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer
about
p21-activated kinase group II small compound inhibitor GNE-2861 perturbs estrogen receptor alpha signaling and restores tamoxifen-sensitivity in breast cancer cellsCCNA2 is a prognostic biomarker for ER+ breast cancer and tamoxifen resistanceCurrent status of the prognostic molecular biomarkers in breast cancer: A systematic reviewFar beyond the usual biomarkers in breast cancer: a review.AEG-1 regulates retinoid X receptor and inhibits retinoid signaling.Comprehensive Proteomic Analysis of Mesenchymal Stem Cell Exosomes Reveals Modulation of Angiogenesis via Nuclear Factor-KappaB Signaling.Proteomics profiling identify CAPS as a potential predictive marker of tamoxifen resistance in estrogen receptor positive breast cancer.Genome-Wide Profiling of PARP1 Reveals an Interplay with Gene Regulatory Regions and DNA Methylation.Cellular and molecular determinants of all-trans retinoic acid sensitivity in breast cancer: Luminal phenotype and RARα expression.Network-based approach to identify prognostic biomarkers for estrogen receptor-positive breast cancer treatment with tamoxifenMulti-level omics analysis in a murine model of dystrophin loss and therapeutic restoration.Blockade of the Hedgehog pathway downregulates estrogen receptor alpha signaling in breast cancer cells.The "busy life" of unliganded estrogen receptors.Targeting to the non-genomic activity of retinoic acid receptor-gamma by acacetin in hepatocellular carcinomaRA and ω-3 PUFA co-treatment activates autophagy in cancer cells.Discovery of Tamoxifen and N-Desmethyl Tamoxifen Protein Targets in MCF-7 Cells Using Large-Scale Protein Folding and Stability Measurements.
P2860
Q28269662-626C30BB-B85F-4B07-8734-754B5D36238FQ28540790-94A8DC59-BFDF-472A-A39F-FD81707C8950Q33598494-E0C36A0F-8475-42E4-9282-591E76F5763CQ33935217-0031D722-B488-4113-A5DE-F4AE430D65DCQ34055706-A0F9406F-BF4E-4F29-8301-07332A8E2DEBQ34509669-44DF0F43-A90C-4407-9284-ABAE2FAA2433Q35313220-FA2FDDED-DD5F-4240-B98D-E15042869A04Q35754577-AEE39BD6-9080-486D-AFBF-A7D3C77A7747Q35904255-7F11EDAC-D902-43F6-81DD-16D0FF82272CQ36214336-F2B6D27E-A323-49CD-8772-03A003BF2B0AQ36252005-5EC9B14F-B849-41B8-BF2B-12211CFFF778Q37687668-0C187A33-A0B9-45FA-84C7-D9D23D524D72Q38618003-7948604B-6977-4752-9648-2FB0D3A15786Q42274085-80A3649C-E2E7-4575-9B53-FF4BD043B331Q47192015-A5287544-9D60-4404-8DCD-907EE169E806Q47777575-85FE5DFB-0A65-42E9-A8D5-C49E9C8939E4
P2860
Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer
@en
Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer.
@nl
type
label
Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer
@en
Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer.
@nl
prefLabel
Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer
@en
Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer.
@nl
P2093
P2860
P50
P356
P1476
Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer
@en
P2093
Anders Hjerpe
Aniko Kovacs
Betzabe C Sanchez
Bo Lundgren
Filip Mundt
Gyöngyvér Máthé
Jenny Forshed
Kamilla Krawiec
Khalil Helou
Lena Kanter
P2860
P2888
P356
10.1038/NCOMMS3175
P407
P577
2013-01-01T00:00:00Z